Breast Tumour Size Measurement by Field Cycling Imaging

The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can accurately estimate tumour size in patients with a type of breast cancer called ductal carcinoma in situ (DCIS). The main question it aims to answer is: Can FCI accurately estimate DCIS lesion size compared with histology results? Participants will have a standard MRI scan and an FCI scan before undergoing surgery to remove the tumour.

NCT Number	NCT07492043
Lead Sponsor	University of Aberdeen Collaborators: NHS Grampian
Conditions	Breast Cancer, Ductal Carcinoma In Situ
Enrollment	12 participants
Start Date	2026-04
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-03-25